🔎 Trials Near Me

Utama › Limfoma Bukan Hodgkin › Illinois › Chicago

Kajian klinikal Limfoma Bukan Hodgkin di Chicago, IL

18 kajian untuk Limfoma Bukan Hodgkin sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Mengambil pesertaFasa 1
  • The University of Chicago Medical Center (UCMC), Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07101328

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • Cancer Treatment Centers of America-Chicago, Chicago
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Mengambil pesertaFasa 2
  • Research Site, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06526793

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Mengambil pesertaFasa 1/2
  • University of Chicago Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Mengambil pesertaFasa 1
  • The David and Etta Jonas Center for Cellular Therapy, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06528301

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Mengambil pesertaKajian pemerhatian
  • Robert H Lurie Cancer Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Mengambil pesertaFasa 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Mengambil pesertaFasa 2
  • Robert H Lurie Cancer Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Mengambil pesertaFasa 1
  • University of Illinois at Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • dan 2 lagi
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Mengambil pesertaFasa 1
  • University of Chicago, Chicago
Umur 13 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Mengambil pesertaFasa 1/2
  • Northwestern Memorial Hospital, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Mengambil pesertaFasa 4
  • Northwestern University, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Mac 2026 · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Mengambil pesertaFasa 4
  • Northwestern University, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Mac 2026 · NCT06876649

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Mengambil pesertaFasa 1
  • Northwestern Memorial Hospital, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Dis 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Chicago
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Limfoma Bukan Hodgkin di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.